Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers

PURPOSE: Combination therapy is a promising strategy to treat cancer due to the synergistic effects. The drug and gene co-delivered systems attract more attention in the field of combination therapy. MATERIALS AND METHODS: In the present research, poly(ethylene glycol)-ε-poly(caprolactone) block cop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiyu, Wei, Yaning, Fang, Guotao, Hong, Dan, An, Lin, Jiao, Ting, Shi, Yan, Zang, Aimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161722/
https://www.ncbi.nlm.nih.gov/pubmed/30288022
http://dx.doi.org/10.2147/DDDT.S175614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161722/
https://www.ncbi.nlm.nih.gov/pubmed/30288022
http://dx.doi.org/10.2147/DDDT.S175614

Ejemplares similares